Skip to main content

Table 2 Detection of galectin-9 in liver specimens from infected (HCV, HBV) or non-infected patients

From: A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses

Patient Gender/Age Medical History Viral diagnosis Histological diagnosis Galectin-9 staining
     Leucocytes or related cells Hepatocytes
1 M/54 Chronic HCV infection HCV cirrhosis with transformed foci - + +
  Alcoholism     
2 M/66 Chronic HCV infection Micronodular cirrhosis associated to a carcinoma + + (aspect of Kupffer cells) + +
  Alcoholism     
3 M/61 Chronic HCV infection Micronodular cirrhosis with transformed foci + +
4 M/67 Chronic HBV infection Macronodular cirrhosis associated to a carcinoma + +
5 M/50 Chronic HBV infection Hepatic fibrosis associated to a carcinoma + + + +
6 M/30 Chronic HBV infection Liver tissue with minimal lesions next to a non-malignant nodule (focal nodular hyperplasia) + + +
7 F/32 No infection Normal liver tissue next to a non-malignant nodule (focal nodular hyperplasia) - -
8 F/20 No infection Normal liver tissue next to an adenoma - -
9 F/28 No infection Normal liver tissue next to an adenoma (with steatosis) - -
  1. ++ : homogeneous galectin-9 staining, + : mild or scattered galectin-9 staining, - : absence of galectin-9 staining.